
Arable
51 Federal St, Suite 301, San Francisco, CA, 94107, United States
Overview
Arable builds an integrated solution combining connected sensors, agronomic models, and a software suite to provide weather, soil, plant-health and irrigation insights for farmers, agronomists and food companies. Its platform combines sensor data and machine learning to support on‑farm decisions, optimize water use, and benchmark sustainability and carbon outcomes. Customers have used Arable to reduce irrigation by up to 50% and pesticide use by about 15% in deployed cases cited by the company. Arable serves customers in over 40 countries and works with partners including Bayer, Netafim, The Nature Conservancy, Treasury Wine Estates and The World Food Programme. The company reports four‑time growth in annual recurring revenue each of the last two years, a 200% increase in active mobile app users over the past 12 months, and has doubled its team while adding offices in Sao Paulo and Bangalore. With the new funding Arable plans to accelerate product development, deliver new services, and expand its global footprint to advance climate resilience in agriculture. Arable provides an integrated system of hardware, agronomic modeling, and software that uses spectral and thermal sensors plus unique rain‑measurement microphones to observe crops continuously and diagnose stress. Its products fuse ground devices, forecasts, satellite data, and APIs to deliver actionable intelligence to farmers, researchers, processors, and food companies. The company reports just over 300% sales growth through Q3 2020 and has deployed thousands of devices across hundreds of thousands of farm acres, covering 37 crops in 39 countries on six continents. Arable’s calibration‑validation network includes more than 30 scientific research sites and its system collects over 36 million data points per day. The team emphasizes data quality, accuracy, and intuitive design and partners with major agriculture players such as Bayer, BASF, Corteva, and Treasury Wine Estates. With the new capital, Arable plans to accelerate global commercial growth and build the next phase of its predictive data products. The company is led by CEO Jim Ethington and Founder & Chief Scientist Adam Wolf and is based in San Francisco, CA. Arable makes solar-powered sensors (Arable Mark, formerly the Pulsepod) and the Arable Insights software platform to collect and analyze plant, light and weather data for farms. Its sensors measure more than 40 different, relevant data types, aiming to provide broader field visibility than single-focus IoT devices. The platform helps farmers automate monitoring, improve forecasting and reduce supply chain risk by surfacing onset of blooms, cluster development and crop coloring. Arable positions its data as valuable to farmers and downstream buyers — processors and grocers — for reducing distribution and procurement risk. The company says the capital raised will be used to hire scientists and engineers and to ramp up sensor production. Arable Labs builds the Pulsepod, a professional-grade, solar-powered crop and weather sensor that pairs with cloud software and developer tools. The device is ruggedly designed by Fred Bould and contains a six-band spectrometer, a 4-way net radiometer and an acoustic rain gauge. Each Pulsepod continuously monitors crop growth, rainfall, crop water demand, light and heat levels and crop color to inform harvest timing and yield forecasts. Data are sent to the cloud and accessible via Arable’s app and API for custom forecasting and analysis. Early adopters include Valley Irrigation, Yara International, Francis Ford Coppola Winery, Treasury Wine Estates, Driscoll’s and Blue Marble Microinsurance. Longer term the company says the sensors could be used beyond agriculture for urban flooding, water quality or fire management, though current focus remains on food farmers and reducing food waste.
- Total raised
- $70M
- Funding rounds
- 5
- Latest round
- Series C
- Latest activity
- Jul 2022
Industries
- Agriculture
- AgTech
- Farming
- Software
Recent funding
Series C
Jul 2022
$40M
Series B
Oct 2020
$20M
Series A
Mar 2017
$4M
Equity
Jul 2016
$2M